86% of All Health Care and Device Companies Report Clinical Operations Groups Involvement in Risk-Based Monitoring Activities
25 oct. 2016 08h17 HE
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - October 25, 2016) - Although drug and device companies do not view dedicated risk-based monitoring (RBM) teams as a necessity, their clinical operations...
Big Pharma's Getting Back Together with Medical Education
20 oct. 2016 08h17 HE
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - October 20, 2016) - Despite a tenuous past relationship, the pharmaceutical industry is getting back together with continuing medical education (CME) events,...
Big Pharma Expanding Patient Centricity through Top-Down Mandates
19 oct. 2016 08h17 HE
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - October 19, 2016) - Drug companies have adopted patient-centric models throughout the pharmaceutical industry. And a new industry study has found that 67% of...
Drug Companies' Launch Sequencing Strategy Influences Approval Team Structure
18 oct. 2016 08h17 HE
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - October 18, 2016) - Research conducted by Cutting Edge Information found that three-fourths of all surveyed pharmaceutical firms reported having ad hoc...
World-Class Medical Affairs: Team Location Impacts Responsibilities
12 oct. 2016 09h04 HE
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - October 12, 2016) - Industry research on global medical affairs responsibilities finds that regional location impacts which responsibilities each team...
Pharma to Clinical Investigators: Reach Target Patient Enrollment or You Don't Get Paid
11 oct. 2016 09h08 HE
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - October 11, 2016) - A study published by Cutting Edge Information found that 87% of surveyed pharmaceutical companies would not submit next-level clinical...
Defining Patient-Centricity Success Metrics & Demonstrating Initiative Value
28 sept. 2016 08h31 HE
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - September 28, 2016) - Although patient centricity becomes evermore prevalent in the pharmaceutical industry, companies have yet to settle on a consistent...
Top 5 Factors Pharma Companies Consider When Compensating Clinical Investigators
27 sept. 2016 08h19 HE
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - September 27, 2016) - The most important factor to determining clinical investigator compensation is the physician's therapeutic specialty, according to a...
Total Market Access Budgets are Increasing for Most Drug Companies
22 sept. 2016 08h54 HE
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - September 22, 2016) - A new study published by Cutting Edge Information found an average $2 million increase in total market access spending by Top 10...
Legal Reviews, Regulatory Mandates and Doctor Payments: Determining KOL Compensation Caps and Policies
21 sept. 2016 10h24 HE
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - September 21, 2016) - Pharmaceutical companies have been under the regulatory spotlight for potentially overpaying physicians that provide them consulting...